Bio-Techne Corp (TECH)
The company now
Bio-Techne Corp is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in Minneapolis, MN. In its latest annual figures on file, for the fiscal year ended 2026-06-30, it reported revenue of $1.2 billion and a profit of $182 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
Where the revenue comes from
fiscal 2026, as filedRevenue by product, fiscal 2026
| Product | Fiscal 2026 | Fiscal 2025 | Share of revenue |
|---|---|---|---|
| Consumables | $985M | $972M | 81.1% |
| Instruments | $111M | $112M | 9.1% |
| Service | $94.3M | $112M | 7.8% |
| Royalty | $25.0M | $23.7M | 2.1% |
Revenue by region, fiscal 2026
| Region | Fiscal 2026 | Fiscal 2025 | Share of revenue |
|---|---|---|---|
| United States | $635M | $683M | 52.3% |
| EMEA, excluding United Kingdom | $294M | $266M | 24.2% |
| China | $104M | $100M | 8.6% |
| APAC, excluding Greater China | $85.8M | $77.3M | 7.1% |
| United Kingdom | $56.3M | $54.8M | 4.6% |
| Rest of World | $39.3M | $37.5M | 3.2% |
As tagged in its annual report (Form 10-K, filed Aug 24, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.
The desk's written account of this company, its Past, Present and Future, is not on file yet.
How the company works
The desk has not read this company's annual report yet.
The record in brief
The desk has not written this company's report yet.